Specification
| Product Details | |
| Generic Name | Capmatinib |
| Strength | 200mg |
| Medicine Form | Tablet |
| Manufactured By | Everest Pharma |
| Quantity | 56 Tablets |
| Packaging Type | Bottle |
Capmaxen Capmatinib 200 mg Tablets is a targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) with mutations leading to mesenchymal-epithelial transition (MET) exon 14 skipping. As a selective MET inhibitor, Capmatinib works by blocking the activity of the MET protein, thereby inhibiting the growth and spread of cancer cells. Our super specialty pharmacy provides high-quality Capmaxen with personalized treatment plans and expert support to ensure the best possible outcomes for patients with METex14 NSCLC. Trust us for effective cancer care and comprehensive support throughout your treatment journey.
